tirzepatide for heart failure 💊 New research in obesity & The SUMMIT study looked at tirzepatide, a once-weekly injection, in people with both obesity and heart failure with preserved ejection fraction (HFpEF). Over 52 AHA 2024: Tirzepatide Lowers Risk

Women of childbearing age need specific counseling

OPTION 1 Book an in-clinic appointment at a clinic of your choice in Cheltenham, Worcester or West Midlands

Methods This observational pre-post study used Optums de-identified Market Clarity Data from January 1, 2007, to June 30, 2024

In addition to demonstrating the noninferiority of insulin glargine U-300 to insulin degludec U-100 with respect to its primary and main secondary endpoints, InRange was the first large randomized controlled trial to use CGM-based TIR as a primary efficacy endpoint, which may herald a shift toward incorporating CGM-based metrics into clinical trials

While branded semaglutide without insurance can be pricey, coverage with assistance from Klinic's prior authorization greatly reduces costs for many clients

Industry experts highlight that Mounjaro outperformed even new global launches (like Wegovy, 28 crore sales since June), underscoring its local market strength